关注
Polona J. Maver
Polona J. Maver
Institute of microbiology and immunology, Faculty of Medicine, University of Ljubljana
在 mf.uni-lj.si 的电子邮件经过验证
标题
引用次数
引用次数
年份
Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans
PJ Maver, M Poljak
Clinical microbiology and infection 26 (5), 579-583, 2020
2452020
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe
M Poljak, K Seme, PJ Maver, BJ Kocjan, KS Cuschieri, SI Rogovskaya, ...
Vaccine 31, H59-H70, 2013
1052013
Classification and nomenclature system for human Alphapapillomavirus variants: general features, nucleotide landmarks and assignment of HPV6 and HPV11 isolates to variant lineages
RD Burk, Z Chen, A Harari, BC Smith, BJ Kocjan, PJ Maver, M Poljak
Acta dermatovenerologica Alpina, Panonica, et Adriatica 20 (3), 113, 2011
882011
Progress in prophylactic human papillomavirus (HPV) vaccination in 2016: A literature review
PJ Maver, M Poljak
Vaccine 36 (36), 5416-5423, 2018
672018
Cervical cancer screening practices in central and eastern Europe in 2012
PJ Maver, K Seme, T Korać, G Dimitrov, L Döbrőssy, L Engele, E Iljazović, ...
Acta Dermatovenerol Alp Pannonica Adriat 22 (1), 7-19, 2013
662013
Identical human papillomavirus (HPV) genomic variants persist in recurrent respiratory papillomatosis for up to 22 years
BJ Kocjan, N Gale, I Hočevar Boltežar, K Seme, K Fujs Komloš, L Hošnjak, ...
The Journal of infectious diseases 207 (4), 583-587, 2013
462013
Human papillomaviruses (HPV) in tissue specimens of oral squamous cell papillomas and normal oral mucosa
AA Kansky, K Seme, PJ Maver, B Luzar, N Gale, M Poljak
Anticancer research 26 (4B), 3197-3201, 2006
372006
Human papillomavirus (HPV) prevalence and HPV type distribution in cervical, vulvar, and anal cancers in central and eastern Europe
M Škamperle, BJ Kocjan, PJ Maver, K Seme, M Poljak
Acta Dermatovenerol Alp Pannonica Adriat 22 (1), 1-5, 2013
352013
Current status of human papillomavirus vaccination implementation in central and eastern Europe
K Seme, PJ Maver, T Korać, A Canton, J Částková, G Dimitrov, I Filippova, ...
Acta Dermatovenerol Alp Pannonica Adriat 22 (1), 21-25, 2013
342013
Comparative evaluation of the Abbott RealTime High Risk HPV test and INNO-LiPA HPV Genotyping Extra test for detecting and identifying human papillomaviruses in archival tissue …
BJ Kocjan, PJ Maver, L Hosnjak, N Zidar, K Odar, N Gale, M Poljak
Acta Dermatovenerol Alp Pannonica Adriat 21 (4), 73-5, 2012
282012
Prevaccination genomic diversity of human papillomavirus genotype 11: A study on 63 clinical isolates and 10 full‐length genome sequences
PJ Maver, BJ Kocjan, K Seme, M Potočnik, N Gale, M Poljak
Journal of medical virology 83 (3), 461-470, 2011
232011
Pre-vaccination genomic diversity of human papillomavirus genotype 6 (HPV 6): a comparative analysis of 21 full-length genome sequences
BJ Kocjan, MM Jelen, PJ Maver, K Seme, M Poljak
Infection, Genetics and Evolution 11 (7), 1805-1810, 2011
222011
Detection and typing of low-risk human papillomavirus genotypes HPV 6, HPV 11, HPV 42, HPV 43 and HPV 44 by polymerase chain reaction and restriction fragment length polymorphism
PJ Maver, M Poljak, K Seme, BJ Kocjan
Journal of virological methods 169 (1), 215-218, 2010
222010
prevalence of HIV type 1 transmitted drug resistance in Slovenia: 2005–2010
MM Lunar, S Židovec Lepej, AB Abecasis, J Tomažič, L Vidmar, P Karner, ...
Aids research and human retroviruses 29 (2), 343-349, 2013
212013
Personal life and working conditions of trainees and young specialists in clinical microbiology and infectious diseases in Europe: a questionnaire survey
AE Maraolo, DSY Ong, J Cortez, K Dedić, D Dušek, A Martin-Quiros, ...
European Journal of Clinical Microbiology & Infectious Diseases 36, 1287-1295, 2017
172017
A large survey among European trainees in clinical microbiology and infectious disease on training systems and training adequacy: identifying the gaps and suggesting improvements
E Yusuf, DSY Ong, A Martin-Quiros, C Skevaki, J Cortez, K Dedić, ...
European Journal of Clinical Microbiology & Infectious Diseases 36, 233-242, 2017
172017
Genomic diversity of low‐risk human papillomavirus genotypes HPV 40, HPV 42, HPV 43, and HPV 44
PJ Maver, BJ Kocjan, K Seme, M Poljak
Journal of medical virology 86 (2), 272-282, 2014
142014
Prevalence, genotype distribution, and risk factors for hepatitis C infection among HIV-infected individuals in Slovenia: a 1986-2013 update
M Skamperle, K Seme, MM Lunar, PJ Maver, J Tomazic, TD Vovko, ...
Acta Dermatovenerologica Alpina, Pannonica et Adriatica 23 (2), 25-27, 2014
92014
Recent advances in prophylactic human papillomavirus (HPV) vaccination: a review of key literature published between September 2017 and September 2018
A Sterbenc, PJ Maver, M Poljak
Acta Dermatovenerol Alp Pannonica Adriat 27 (4), 193-201, 2018
82018
Prevalence, genotype distribution, and risk factors for hepatitis C infection among HIV-infected individuals in Slovenia: a 1986–2013 update
M Škamperle, K Seme, MM Lunar, PJ Maver, J Tomažič, TD Vovko, ...
Acta Dermatovenerol Alp Pannonica Adriat 23 (2), 25-26, 2014
52014
系统目前无法执行此操作,请稍后再试。
文章 1–20